Production Method 1

130777-67-2

959058-28-7

170656-93-6

87532-69-2

Reaction Conditions

1.1 Solvents: Toluene ;  1 h, rt; 5 d, 65 °C
2.1 Solvents: Toluene-d8 ;  2 d, 80 °C; 1 h, 80 °C → 100 °C; 5 h, 100 °C

Reference

Reduction of CO2 and SO2 with low valent nickel compounds under mild conditions

Gonzalez-Sebastian, Lucero; et al, Dalton Transactions, 2011, 40(36), 9116-9122

Production Method 2

1345977-93-6

959058-28-7

170656-93-6

87532-69-2

Reaction Conditions

1.1 Solvents: Toluene-d8 ;  2 d, 80 °C; 1 h, 80 °C → 100 °C; 5 h, 100 °C

Reference

Reduction of CO2 and SO2 with low valent nickel compounds under mild conditions

Gonzalez-Sebastian, Lucero; et al, Dalton Transactions, 2011, 40(36), 9116-9122

[2-[Bis(1-methylethyl)phosphino]ethyl]bis(1-methylethyl)phosphine oxide Raw materials

• Nickel, bis[1,1'-(1,2-ethanediyl)bis[1,1-bis(1-methylethyl)phosphine-κP]]di-μ-hydrodi-, (Ni-Ni)

[2-[Bis(1-methylethyl)phosphino]ethyl]bis(1-methylethyl)phosphine oxide Preparation Products

• [2-[Bis(1-methylethyl)phosphino]ethyl]bis(1-methylethyl)phosphine oxide (959058-28-7)
• (170656-93-6)
• Phosphine, 1,2-ethanediylbis[bis(1-methylethyl)- (87532-69-2)

• 1. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 2. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 3. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 4. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 5. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)